Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Richter Gedeon Nyrt has 1 pending office action in Biotechnology & Pharmaceuticals. The matter is handled by 1 examiner in 1 art unit, making the examination structure direct and localized.
LOUNTOS, GEORGE THEMISTOCLIS is the assigned examiner. Counsel can concentrate on the pending record and align claim and disclosure arguments to that single technical setting.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LOUNTOS, GEORGE THEMISTOCLIS | 1 | 57.1% | +60.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18890829 | METHOD FOR THE MANUFACTURE OF BIOPHARMACEUTICALS | LOUNTOS, GEORGE THEMISTOCLIS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18890829 | METHOD FOR THE MANUFACTURE OF BIOPHARMACEUTICALS | LOUNTOS, GEORGE THEMISTOCLIS | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18890829 | METHOD FOR THE MANUFACTURE OF BIOPHARMACEUTICALS | LOUNTOS, GEORGE THEMISTOCLIS | 1652 | §103§112 | Non-Final OA | — | Pending | Sep 20, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRichter Gedeon Nyrt has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
George Themistoclis Lountos has the most, with 1 of Richter Gedeon Nyrt's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
